Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / IMGN - ImmunoGen inks deal to commercialize antibody-drug conjugate in Greater China

IMGN - ImmunoGen inks deal to commercialize antibody-drug conjugate in Greater China

ImmunoGen Inc.
ImmunoGen ([[IMGN]] -0.9%) has agreed to partner with Huadong Medicine Co., Ltd. subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize mirvetuximab soravtansine in Greater China (mainland, Hong Kong, Macau and Taiwan).Under the terms of the deal, IMGN will receive $40M upfront, up to $265M in milestones and low double-digit-to-high-teen royalties on net sales.IMGN retains all rights to the antibody-drug conjugate in the rest of the world.

For further details see:

ImmunoGen inks deal to commercialize antibody-drug conjugate in Greater China
Stock Information
Company Name: ImmunoGen Inc.
Stock Symbol: IMGN
Market: NASDAQ
Website: immunogen.com
Menu
IMGN IMGN Quote IMGN Short IMGN News IMGN Articles IMGN Message Board
Get IMGN Alerts

News, Short Squeeze, Breakout and More Instantly...